JP2018502600A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018502600A5 JP2018502600A5 JP2017552233A JP2017552233A JP2018502600A5 JP 2018502600 A5 JP2018502600 A5 JP 2018502600A5 JP 2017552233 A JP2017552233 A JP 2017552233A JP 2017552233 A JP2017552233 A JP 2017552233A JP 2018502600 A5 JP2018502600 A5 JP 2018502600A5
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- plasmid
- seq
- amino acid
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1451658 | 2014-12-23 | ||
| SE1451658-7 | 2014-12-23 | ||
| PCT/EP2015/081146 WO2016102660A1 (en) | 2014-12-23 | 2015-12-23 | Methods for wound healing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019156412A Division JP7033109B2 (ja) | 2014-12-23 | 2019-08-29 | 創傷治癒の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018502600A JP2018502600A (ja) | 2018-02-01 |
| JP2018502600A5 true JP2018502600A5 (https=) | 2018-03-22 |
| JP6581208B2 JP6581208B2 (ja) | 2019-09-25 |
Family
ID=55080095
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017552233A Active JP6581208B2 (ja) | 2014-12-23 | 2015-12-23 | 創傷治癒の方法 |
| JP2019156412A Active JP7033109B2 (ja) | 2014-12-23 | 2019-08-29 | 創傷治癒の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019156412A Active JP7033109B2 (ja) | 2014-12-23 | 2019-08-29 | 創傷治癒の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US10696974B2 (https=) |
| EP (2) | EP3237622B1 (https=) |
| JP (2) | JP6581208B2 (https=) |
| KR (2) | KR102297619B1 (https=) |
| CN (2) | CN113403244B (https=) |
| AU (2) | AU2015370982B2 (https=) |
| CA (1) | CA2971520C (https=) |
| ES (2) | ES2864373T3 (https=) |
| WO (1) | WO2016102660A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10973852B2 (en) | 2016-01-25 | 2021-04-13 | Nantcell, Inc. | NK cells with altered CXCL12/CXCR4 signaling |
| US20190300843A1 (en) * | 2016-10-31 | 2019-10-03 | Kimberly-Clark Worldwide, Inc. | Method for archiving a microbiome |
| US20240024388A1 (en) * | 2017-02-17 | 2024-01-25 | The University Of British Columbia | Probiotic compositions and uses thereof |
| CN110157733A (zh) * | 2018-02-11 | 2019-08-23 | 四川大学 | 重组mIL-22BP载体、脂质体复合物及其制备方法和用途 |
| CN112236513B (zh) | 2018-07-24 | 2023-09-19 | 生命大地女神有限公司 | 选择和使用褪黑素支持细菌以减少婴儿绞痛 |
| CA3103356A1 (en) * | 2018-07-24 | 2020-01-30 | Biogaia Ab | Therapeutic methods using bacterial strains which are capable of increasing adenosine levels |
| CN109112155A (zh) * | 2018-08-02 | 2019-01-01 | 南昌大学 | 乳酸乳球菌mg1363的构建及其在治疗细菌性阴道炎中的应用 |
| CN109234298A (zh) * | 2018-10-30 | 2019-01-18 | 南昌大学 | 一种卷曲乳杆菌atcc55221的构建及其在治疗产妇乳头皲裂中的应用 |
| CN109517772A (zh) * | 2018-10-30 | 2019-03-26 | 南昌大学 | 一种乳酸乳球菌mg1363的构建及其在治疗产妇乳头皲裂中的应用 |
| JP7045671B2 (ja) * | 2018-11-12 | 2022-04-01 | 有限会社バイオ研 | 皮膚塗布用の皮膚創傷治癒促進組成物、その製造方法、及び創傷被覆材 |
| WO2020261055A1 (en) * | 2019-06-24 | 2020-12-30 | Mendes S.R.L. | Composition with antibacterial and re-epithelializing action including probiotics |
| CN110623792B (zh) * | 2019-09-23 | 2022-05-06 | 温州医科大学附属第一医院 | 一种医学敷料及其制备方法 |
| CN114470007B (zh) * | 2020-11-13 | 2024-10-18 | 葡萄王生技股份有限公司 | 含乳酸菌发酵产物之皮肤创伤外用组合物及其用途 |
| CA3228922A1 (en) | 2021-10-11 | 2023-04-20 | Ajinomoto Co., Inc. | Bacterium modified to express heterologous tat protein |
| WO2023118327A1 (en) | 2021-12-22 | 2023-06-29 | Ilya Pharma Ab | Live bacteria as excipients for proteins |
| JP2025504333A (ja) * | 2021-12-29 | 2025-02-12 | イリヤ ファーマ エービー | 治療誘発腸症の処置 |
| KR102752056B1 (ko) * | 2023-07-12 | 2025-01-13 | 전남대학교 산학협력단 | 락토바실러스 루터리(Lactobacillus reuteri) NCHBL-005 균주를 포함하는 창상 예방 또는 치료, 피부 재생 촉진용 조성물 |
| GB202405882D0 (en) | 2024-04-26 | 2024-06-12 | Ilya Pharma Ab | Treatment of mdr infections |
| CN118948906B (zh) * | 2024-10-16 | 2025-02-14 | 温州医科大学附属第一医院 | 一种促进创面愈合的乳酸杆菌生物膜衍生物及其制备方法和应用 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9521568D0 (en) * | 1995-10-20 | 1995-12-20 | Lynxvale Ltd | Delivery of biologically active polypeptides |
| ATE438718T1 (de) * | 1997-02-07 | 2009-08-15 | Shionogi & Co | Neuer cxc chemokinrezeptor aus maus |
| PT1739178E (pt) | 1999-07-05 | 2010-11-17 | Actogenix Nv | Libertação de péptidos trifólios |
| CA2311201A1 (en) | 1999-08-05 | 2001-02-05 | Genset S.A. | Ests and encoded human proteins |
| US7780961B2 (en) | 2001-05-03 | 2010-08-24 | Actogenix N.V. | Self-containing Lactococcus strain |
| WO2006124013A2 (en) * | 2004-04-30 | 2006-11-23 | Five Prime Therapeutics, Inc. | Novel stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof, and method of use |
| US9200249B2 (en) | 2004-08-20 | 2015-12-01 | Actogenix N.V. | Method to improve Lactococcus preservation |
| ES2626610T3 (es) | 2005-08-30 | 2017-07-25 | Intrexon Actobiotics Nv | Bacterias de ácido láctico productoras del anti-TNF alfa para el tratamiento de la enfermedad inflamatoria intestinal |
| WO2007039586A1 (en) | 2005-10-03 | 2007-04-12 | Actogenix Nv | Use of recombinant yeast strain producing an anti -inflammatory compound in the manufacture of a medicament to treat colitis |
| ES2405552T3 (es) | 2005-11-29 | 2013-05-31 | Actogenix N.V. | Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos |
| US8852916B2 (en) | 2010-01-22 | 2014-10-07 | The Invention Science Fund I, Llc | Compositions and methods for therapeutic delivery with microorganisms |
| US8682619B2 (en) * | 2005-12-14 | 2014-03-25 | The Invention Science Fund I, Llc | Device including altered microorganisms, and methods and systems of use |
| EP2016178B1 (en) | 2006-05-02 | 2017-07-12 | Intrexon Actobiotics NV | Microbial intestinal delivery of obesity related peptides |
| CA2672229A1 (en) | 2006-12-14 | 2008-06-19 | Actogenix N.V. | Delivery of binding molecules to induce immunomodulation |
| CA2673409A1 (en) | 2006-12-19 | 2009-06-26 | Ferrosan A/S | Wound or tissue dressing comprising lactic acid bacteria |
| US20100143447A1 (en) | 2006-12-19 | 2010-06-10 | Ferrosan A/S | Wound or tissue dressing comprising lactic acid bacteria |
| AU2008204442B2 (en) | 2007-01-12 | 2013-03-14 | Intrexon Actobiotics Nv | Lactococcus promoters and uses thereof |
| WO2008090223A2 (en) | 2007-01-25 | 2008-07-31 | Actogenix N.V. | Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus |
| WO2008096359A2 (en) * | 2007-02-08 | 2008-08-14 | Rappaport Family Institute For Research In The Medical Sciences | Agents for the treatment of multiple sclerosis and methods of using same |
| WO2008155120A2 (en) | 2007-06-20 | 2008-12-24 | Actogenix Nv | Methods and compositions for treating mucositis |
| EP2218459B1 (en) | 2007-11-07 | 2012-02-01 | Ono Pharmaceutical Co., Ltd. | Sustained release composition containing sdf-1 |
| CA2709398C (en) | 2007-12-14 | 2017-11-07 | The Cleveland Clinic Foundation | Use of stromal cell-derived factor 1 for promoting wound healing |
| US8367109B2 (en) | 2008-04-09 | 2013-02-05 | Brookhaven Science Associates, Llc | Microbes encapsulated within crosslinkable polymers |
| EP3181682B1 (en) | 2008-09-29 | 2021-04-21 | Intrexon Actobiotics NV | Reduced colonization of microbes at the mucosa |
| US20100143305A1 (en) * | 2008-12-08 | 2010-06-10 | James Allen Lemke | Treatment of hiv and aids using probiotic lactobacillus reuteri |
| US20120058086A1 (en) | 2009-04-21 | 2012-03-08 | Velazquez Omaida C | Compositions, kits, and methods for promoting ischemic and diabetic wound healing |
| EP2243487A1 (en) | 2009-04-23 | 2010-10-27 | Actogenix N.V. | Enteric coated formulation |
| CA2760248C (en) | 2009-04-30 | 2019-05-28 | Actogenix Nv | Cryoprotectants for freeze drying of lactic acid bacteria |
| CN102459571B (zh) * | 2009-06-04 | 2014-01-08 | 香港中文大学 | 抗炎细菌 |
| CL2009001506A1 (es) | 2009-07-01 | 2009-09-25 | Univ Concepcion | Parche o aposito a base de hidrocoloides compuesto por una lamina de gelatina reticulada que comprende cepas viables probioticas productoras de acido lactico de lactobacillus acidophilus dsm 17371, un agente reticulante y un agente plastificante; y proceso para elaborar dicho parche. |
| WO2011026041A2 (en) | 2009-08-28 | 2011-03-03 | The Cleveland Clinic Foundation | Sdf-1 delivery for treating ischemic tissue |
| US20120183503A1 (en) | 2009-09-29 | 2012-07-19 | Actogenix N.V. | Lactobacillus and streptococcus promoters and uses thereof |
| GB2482536B (en) * | 2010-08-05 | 2013-07-24 | Hera Pharmaceuticals Inc | Expression of antibody or a fragment thereof in lactobacillus |
| CN101985052B (zh) | 2010-08-31 | 2013-11-06 | 中国人民解放军第二军医大学 | 自动捕获内皮祖细胞促进血管化的皮肤替代物及其构建方法 |
| US20140065209A1 (en) | 2011-05-03 | 2014-03-06 | Dupont Nutrition Biosciences Aps | Probiotic bacteria for the topical treatment of skin disorders |
| WO2012164083A1 (en) | 2011-06-01 | 2012-12-06 | Actogenix N.V. | Polycistronic expression system for bacteria |
| JP6117212B2 (ja) | 2011-09-23 | 2017-04-19 | イントレクソン・アクトバイオテイクス・エヌブイＩｎｔｒｅｘｏｎ Ａｃｔｏｂｉｏｔｉｃｓ ＮＶ | 改変されたグラム陽性菌及びその使用 |
| HUE038336T2 (hu) | 2011-09-23 | 2018-10-29 | Intrexon Actobiotics Nv | Módosított gram-pozitív baktériumok és alkalmazásaik |
| GB201206599D0 (en) | 2012-04-13 | 2012-05-30 | Univ Manchester | Probiotic bacteria |
| EA031883B1 (ru) | 2013-03-15 | 2019-03-29 | Джувентас Терапьютикс, Инк. | Способ ингибирования и/или снижения образования рубцовой ткани |
| WO2014146202A1 (en) * | 2013-03-18 | 2014-09-25 | London Health Sciences Centre Research Inc. | Bacteria for the prevention, treatment and diagnosis of breast cancer |
| CN105658217B (zh) | 2013-04-29 | 2021-03-19 | 约翰霍普金斯大学 | 经由自体干细胞动员的创伤愈合 |
| WO2016124239A1 (en) | 2015-02-04 | 2016-08-11 | Aurealis Oy | Recombinant probiotic bacteria for use in the treatment of a skin dysfunction |
-
2015
- 2015-12-23 US US15/538,384 patent/US10696974B2/en active Active
- 2015-12-23 ES ES15822941T patent/ES2864373T3/es active Active
- 2015-12-23 JP JP2017552233A patent/JP6581208B2/ja active Active
- 2015-12-23 EP EP15822941.9A patent/EP3237622B1/en active Active
- 2015-12-23 KR KR1020207004865A patent/KR102297619B1/ko active Active
- 2015-12-23 CN CN202110680754.6A patent/CN113403244B/zh active Active
- 2015-12-23 CA CA2971520A patent/CA2971520C/en active Active
- 2015-12-23 WO PCT/EP2015/081146 patent/WO2016102660A1/en not_active Ceased
- 2015-12-23 ES ES20161504T patent/ES3048233T3/es active Active
- 2015-12-23 AU AU2015370982A patent/AU2015370982B2/en active Active
- 2015-12-23 KR KR1020177020505A patent/KR102081493B1/ko active Active
- 2015-12-23 EP EP20161504.4A patent/EP3735979B1/en active Active
- 2015-12-23 CN CN201580070791.8A patent/CN107208107B/zh active Active
-
2019
- 2019-06-19 AU AU2019204290A patent/AU2019204290B2/en active Active
- 2019-08-29 JP JP2019156412A patent/JP7033109B2/ja active Active
-
2020
- 2020-06-05 US US16/893,781 patent/US11473091B2/en active Active
-
2022
- 2022-08-11 US US17/819,274 patent/US20230093013A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018502600A5 (https=) | ||
| JP6866974B2 (ja) | 新規なエンドリシンポリペプチド | |
| Borrero et al. | Modified lactic acid bacteria detect and inhibit multiresistant enterococci | |
| JP2021501581A5 (https=) | ||
| NZ602943A (en) | Modified binding proteins inhibiting the vegf-a receptor interaction | |
| GB201018518D0 (en) | Novel endolysin | |
| MX2018009225A (es) | Inmunoterapia basada en vectores de distribución personalizados y usos de la misma. | |
| Chen et al. | Cloning and heterologous expression of a bacteriocin sakacin P from Lactobacillus sakei in Escherichia coli | |
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| HRP20241279T1 (hr) | Pripravak koji sadrži probiotike koji prekomjerno eksprimiraju protein clpb za uporabu u liječenju pretilosti | |
| RU2017142932A (ru) | Фармацевтические и пищевые композиции для индуцирования насыщения и продления сытости у нуждающихся в этом субъектов | |
| Zhang et al. | Mammary gland expression of antibacterial peptide genes to inhibit bacterial pathogens causing mastitis | |
| WO2017084985A1 (en) | Bacteriocin composition and method | |
| JP2021526802A5 (https=) | ||
| Sivaraj et al. | Potential applications of lactic acid bacteria and bacteriocins in anti-mycobacterial therapy | |
| ES2808780T3 (es) | Nuevos péptidos antimicrobianos, sus variantes y usos | |
| JP2013542942A5 (https=) | ||
| Silpa et al. | Cyclic peptide production from lactic acid bacteria (LAB) and their diverse applications | |
| WO2010012972A3 (en) | Novel bacterial cells and uses thereof | |
| Niu et al. | Full‐length cDNA, prokaryotic expression, and antimicrobial activity of UuHb‐F‐I from Urechis unicinctus | |
| IL297430A (en) | Chimeric endolysin polypeptide | |
| WO2019033007A3 (en) | Staphylococcus pseudintermedius virulence factor compositions | |
| O’Sullivan et al. | Nisin variants from Streptococcus and Staphylococcus successfully express in NZ9800 | |
| WO2019059817A9 (en) | VACCINE BASED ON FUSION PROTEIN AND PLASMIDIC DNA | |
| CN107849103B (zh) | 新抗微生物肽、它们的变体和用途 |